Effects of Virtual Reality on Rehabilitation in Patients With Heart Failure
Launched by VALENTINA MICHELUZZI · Oct 30, 2023
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how virtual reality (VR) can help patients with heart failure stick to their rehabilitation programs. Heart failure can make it hard for the heart to pump blood effectively, and rehabilitation is crucial for improving patients' health. Unfortunately, many patients don't complete these programs. By using VR as part of the rehabilitation process, the study aims to see if it can encourage more patients to participate and improve their overall health outcomes, including their ability to exercise and quality of life.
To be eligible for the trial, participants need to be at least 18 years old and have a specific type of heart failure where their heart's pumping ability is reduced. Those with certain conditions that could prevent them from exercising or using VR will not be included. If selected, participants will take part in two 30-minute rehabilitation sessions each week for a month, either using VR or following standard rehabilitation exercises. This exciting research could lead to new ways to support heart failure patients and help them feel better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age over 18 years;
- • clinically stable chronic HF diagnosis with left ventricular ejection fraction (LVEF) \< 40%
- Exclusion Criteria:
- • conditions that exclude exercise training (e.g., bone fractures);
- • conditions that exclude VR use of VR (e.g., blindness and deafness
- • severe cognitive impairment, documented with a score of 0 - 4 on the Six-item Screener;
- • end-stage renal disease requiring dialysis;
- • ascertained advanced pneumopathies;
- • active neoplasms;
- • rheumatic diseases.
About Valentina Micheluzzi
Valentina Micheluzzi is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on improving patient outcomes, Micheluzzi oversees the design, implementation, and management of clinical trials across various therapeutic areas. Her expertise in regulatory compliance and trial methodology ensures that studies adhere to the highest ethical standards and scientific rigor. Valentina's collaborative approach fosters strong partnerships with researchers, healthcare professionals, and institutions, driving the successful development of new treatments and therapies to meet unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sassari, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported